RNU6-165P

Across TCGA pan-cancer cohorts, RNU6-165P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU6-165P data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher RNU6-165P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-165P expression acts as an unfavorable survival marker, although some lineages such as KIRP show a favorable association.

READ, ESCA, and LGG are the cancer types where RNU6-165P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	All	0.269	0.819	.009	45	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
LGG	OS	Tertile	All	0.495	0.897	<.001	36	view →
SKCM	DFS	Tertile	III,IV	0.043	0.597	<.001	30	view →
STAD	DFS	Tertile	IV	0.097	0.412	.008	18	view →
UCEC	OS	Tertile	IV	0.231	0.592	.036	18	view →
KIRC	DFS	Tertile	All	0.670	0.799	.017	12	view →
KIRP	DFS	Tertile	III,IV	1.000	0.309	.045	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU6-165P–READ (DFS)

Open the READ breakdown →